Hey,
I was listening to Dougs preso just then, but couldn't find anything concrete.
The CLIA thing shouldn't affect this, as pretty much all pre-natal mandatory tests are through big pathology companies.
Interesting position this company finds itself in. If the corner hasn't been turned, it's at least in full view.
It was the Q4 2024 webcast.
Did I miss it (highly probable at my age) or was it in another?
Thanks mate
Ann: Lumos Receives US$400k Phase 1 Milestone from Hologic, page-34
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.001(3.13%) |
Mkt cap ! $23.11M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.2¢ | 3.0¢ | $32.35K | 1.037M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 207934 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 443315 | 3 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| LDX (ASX) Chart |